Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer

No abstract available
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Letters to the Editor Source Type: research